Cited 27 times in

Delivery of Cancer Therapeutics Using Nanotechnology

Title
 Delivery of Cancer Therapeutics Using Nanotechnology
Authors
 Eun-Kyung Lim; Eunji Jang; Yong-Min Huh; Seungjoo Haam; Kwangyeol Lee
Issue Date
2013
Journal Title
 Pharmaceutics
ISSN
 1999-4923
Citation
 Pharmaceutics, Vol.5(2) : 294~317, 2013
Abstract
Nanoparticles have been investigated as drug carriers, because they provide a great opportunity due to their advantageous features: (i) various formulations using organic/inorganic materials, (ii) easy modification of targeting molecules, drugs or other molecules on them, (iii) effective delivery to target sites, resulting in high therapeutic efficacy and (iv) controlling drug release by external/internal stimuli. Because of these features, therapeutic efficacy can be improved and unwanted side effects can be reduced. Theranostic nanoparticles have been developed by incorporating imaging agents in drug carriers as all-in-one system, which makes it possible to diagnose and treat cancer by monitoring drug delivery behavior simultaneously. Recently, stimuli-responsive, activatable nanomaterials are being applied that are capable of producing chemical or physical changes by external stimuli. By using these nanoparticles, multiple tasks can be carried out simultaneously, e.g., early and accurate diagnosis, efficient cataloguing of patient groups of personalized therapy and real-time monitoring of disease progress. In this paper, we describe various types of nanoparticles for drug delivery systems, as well as theranostic systems.
URI
http://ir.ymlib.yonsei.ac.kr/handle/22282913/86735
DOI
10.3390/pharmaceutics5020294
Appears in Collections:
1. 연구논문 > 1. College of Medicine > Dept. of Radiology
1. 연구논문 > 5. Research Institutes > Institute for Medical Convergence
Yonsei Authors
사서에게 알리기
  feedback
Files in This Item:
T201301230.pdfDownload
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse